Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Menu

Corvus Pharma Com (CRVS)

Corvus Pharma Com (CRVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Corvus Pharmaceuticals Announces Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis GlobeNewswire - Wed Dec 18, 6:30AM CST

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals to Release Interim Data from Phase 1 Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024 Quiver Quantitative, Inc. - Wed Dec 18, 1:24AM CST

Corvus Pharmaceuticals will announce interim Phase 1 trial data for soquelitinib in atopic dermatitis on December 18, 2024.Quiver AI SummaryCorvus Pharmaceuticals, Inc. will release interim data from its...

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals to Announce Interim Data from Placebo-Controlled Phase 1 Clinical Trial of Soquelitinib for Atopic Dermatitis on December 18, 2024 GlobeNewswire - Tue Dec 17, 3:01PM CST

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Publishes Preclinical Data on Soquelitinib's Potential to Modulate Tumor Immunity Quiver Quantitative, Inc. - Thu Dec 5, 1:20AM CST

Corvus Pharmaceuticals publishes preclinical data on soquelitinib, highlighting its potential in cancer immunotherapy and immune disease treatment.Quiver AI SummaryCorvus Pharmaceuticals has published...

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Announces Publication of Biochemistry and Preclinical Data Demonstrating Potential of ITK Inhibition with Soquelitinib as a Novel Approach to Modulate Tumor Immunity GlobeNewswire - Wed Dec 4, 3:05PM CST

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Presents New Preclinical Data Supporting Soquelitinib's Efficacy in Systemic Sclerosis at ACR Convergence 2024 Quiver Quantitative, Inc. - Thu Nov 14, 8:00PM CST

Corvus Pharmaceuticals presents new preclinical data on soquelitinib's efficacy against immune diseases at ACR Convergence 2024.Quiver AI SummaryCorvus Pharmaceuticals has announced preclinical data supporting...

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Announces New Preclinical Data Highlighting Potential of Soquelitinib to Treat Systemic Sclerosis GlobeNewswire - Thu Nov 14, 9:01AM CST

CRVS : 4.99 (-1.96%)
Corvus: Q3 Earnings Snapshot AP - Tue Nov 12, 3:13PM CST

Corvus: Q3 Earnings Snapshot

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Provides Business Update and Reports Third Quarter 2024 Financial Results GlobeNewswire - Tue Nov 12, 3:01PM CST

CRVS : 4.99 (-1.96%)
Corvus Pharmaceuticals Announces New Data Highlighting Potential of Ciforadenant to Overcome Immunotherapy Resistance in Metastatic Castration Resistant Prostate Cancer GlobeNewswire - Sat Nov 9, 12:40PM CST

CRVS : 4.99 (-1.96%)

Barchart Exclusives

Scalp a 47% Payout by the End of This Week with Micron (MU) Call Spreads Barchart - Sat Dec 21, 9:15AM CST
Yes, there are serious questions about MU stock following the underlying company’s disappointing earnings but a steady march is all options traders need. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot